In the year 2018, Europe Antinuclear Antibody Test Market was valued at USD 260.1 Million. By the year 2023, it is expected to reach USD 464.56 Million at pace of 12.30% CAGR.
Antinuclear antibodies (ANA) are used to detect or evaluate the presence of autoimmune diseases affecting body tissues and organs. These are mainly found in patients whose immune system causes inflammation against their own body tissues. It is commonly used to diagnose rheumatoid arthritis, systemic lupus ... Read more